PIPA5114514

SLC30A8 Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA5114514-Each-of-1 In Stock ₹ 46,502.50

PIPA5114514 - Each of 1

₹ 46,502.50

In Stock

Quantity

1

Base Price: ₹ 46,502.50

GST (18%): ₹ 8,370.45

Total Price: ₹ 54,872.95

Antigen

SLC30A8

Classification

Polyclonal

Conjugate

Unconjugated

Gene

SLC30A8

Gene Alias

C820002P14Rik; LOW QUALITY PROTEIN: uncharacterized protein slc30a8; Slc30a8; solute carrier family 30 (zinc transporter), member 8; solute carrier family 30 member 8; wu:fe49g03; Zinc transporter 8; zinc transporter 8; LOW QUALITY PROTEIN: zinc transporter 8; zinc transporter ZnT-8; Znt8; ZnT-8

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

169026

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Form

Liquid

Applications

Immunohistochemistry (Paraffin), Western Blot

Concentration

1 mg/mL

Formulation

PBS with 0.02% sodium azide

Gene Accession No.

Q8IWU4

Gene Symbols

SLC30A8

Immunogen

SLC30A8 antibody was raised against a peptide corresponding to 14 amino acids near the amino terminus of human SLC30A8.

Quantity

100 μg

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA5114359

--

Img

Thermo Scientific

PIPA5114452

--

Img

Thermo Scientific

PIPA5114467

--

Img

Thermo Scientific

PIPA5114516

--

Img

Thermo Scientific

PIPA5114472

--

Img

Thermo Scientific

PIPA5114526

--

Img

Thermo Scientific

PIPA5114503

--

Img

Thermo Scientific

PIPA5114509

--

Description

  • Positive controls that may be used include: Human Pancreas Tissue Lysate Slc30A8 is a zinc efflux transporter involved in the accumulation of zinc in intracellular vesicles and is expressed at a high level in the pancreas, particularly in islets of Langerhans, and co-localizes with insulin in the secretory pathway granules of the insulin-secreting INS-1 cells
  • Allelic variants of Slc30A8 have been identified as major genetic risk factors for the development of Type 2 diabetes, but no genetic association has been found with Type 1 diabetes
  • Slc30A8 expression in b-cells was found to be influenced by cytokine expression, particularly IFN-gamma and IL-1 beta.